BKYI

BIO-key International, Inc. Common Stock

0.58

USD

BKYI Earnings Reports

Positive Surprise Ratio

BKYI beat 7 of 30 last estimates.

23%

Next Report

Date of Next Report

Mar 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$2.24M

-$0.07

Implied change from Q3 25 (Revenue/ EPS)

+44.87%

-53.33%

Implied change from Q4 24 (Revenue/ EPS)

+53.49%

-86.79%

BIO-key International, Inc. Common Stock earnings per share and revenue

On Nov 14, 2025, BKYI reported earnings of -0.15 USD per share (EPS) for Q3 25, missing the estimate of -0.12 USD, resulting in a -22.55% surprise. Revenue reached 1.55 million, compared to an expected 1.84 million, with a -15.63% difference. The market reacted with a -2.37% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 2.24 million USD, implying an decrease of -53.33% EPS, and increase of 44.87% in Revenue from the last quarter.

FAQ

What were BIO-key International, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, BIO-key International, Inc. Common Stock reported EPS of -$0.15, missing estimates by -22.55%, and revenue of $1.55M, -15.63% below expectations.

How did the market react to BIO-key International, Inc. Common Stock's Q3 2025 earnings?

The stock price moved down -2.37%, changed from $0.97 before the earnings release to $0.95 the day after.

When is BIO-key International, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 25, 2026.

What are the forecasts for BIO-key International, Inc. Common Stock's next earnings report?

Based on 3 analysts, BIO-key International, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $2.24M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.